Waters Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Waters Corporation inventory turnover ratio, the Waters Corporation's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2 in the second quarter 2026, yet the ratio remained below the average, as WAT's market remain challenging.Average inventory processing period, for the Waters in Jul 04 2026 quarter, has decreased to 183 days, compare to 224 days, in the Apr 04 2026 quarter.

Within Healthcare sector 205 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1295 in the first quarter 2026, to 1672.

WAT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Waters Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

WAT Inventory Turnover Ratio	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Inventory Growth	154.64 %	192.47 %	19.93 %	10.39 %	3.41 %
Y / Y Cost of Sales Growth	354.38 %	210.87 %	4.12 %	-30.17 %	-30.44 %
Inventory Turnover Ratio (TTM)	2	1.63	1.72	1.77	1.99
WAT's Total Ranking	# 1672	# 1295	# 1183	# 518	# 926
Average inventory processing period	183	224	213	207	183
Seq. Inventory Growth	-7.95 %	161.37 %	-0.1 %	5.95 %	5.72 %
Seq. Cost of Sales Growth	73.85 %	44.41 %	72.27 %	5.06 %	18.95 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 8
Healthcare Sector	# 206
Overall Market	# 1672

Inventory Turnover Ratio Statistics
High	Average	Low
3.49	2.89	1.62
(Dec. 30. 2007)		(Jul 02 2016)

WAT Company Profile >> Back to WAT Efficiency Comparisons >> Compare WAT Inventory Turnover Ratio to its Competitors

Financial Statements
Waters's Inventories	$ 1,377 Millions	Visit WAT's Balance sheet
Waters's Cost of Revenues TTM	$ 2,008 Millions	Visit WAT's Income Statement
What are WAT's Sales?		Visit WAT's Sales by Segment

Other Inventory Turnover Ratios
Waters's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
WAT's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for WAT's Competitors
Inventory Turnover Ratio for WAT's Suppliers
Inventory Turnover Ratio for WAT's Customers

You may also want to know
WAT's Sales Growth Rates	WAT's Pe Price to earnings ratio	WAT's Receivables Turnover Ratio	WAT's Stock Quote
WAT's Net Income Growth Rates	WAT's Ps Price to Sales ratio	WAT's Sales per Employee	WAT's Asset Turnover Ratio
WAT's Net Margin	WAT's Pb Price to Book ratio	WAT's Financial Strength Ratios	WAT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jul 04 2026	Inventories at quarter ending Jul 04 2026
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Escalon Medical Corp	3.94	$ 7.167 Millions	$ 2 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Abbvie Inc	3.66	$ 18,365.000 Millions	$ 5,016 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Baxter International Inc	3.46	$ 8,020.000 Millions	$ 2,317 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Cadre Holdings inc	3.39	$ 399.991 Millions	$ 118 Millions
Bausch Health Companies Inc	3.38	$ 3,783.000 Millions	$ 1,120 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
Evolus Inc	3.37	$ 105.904 Millions	$ 31 Millions
Gilead Sciences Inc	3.35	$ 6,217.000 Millions	$ 1,857 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions
Exelixis Inc	3.28	$ 85.665 Millions	$ 26 Millions
Biofrontera Inc	3.28	$ 6.622 Millions	$ 2 Millions
Becton Dickinson And Company	3.25	$ 11,161.000 Millions	$ 3,429 Millions
Maravai Lifesciences Holdings Inc	3.22	$ 135.038 Millions	$ 42 Millions
Solventum Corporation	3.22	$ 3,421.000 Millions	$ 1,061 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.